BridgeMD
SERRATUS : Evaluation of the Analgesia by Serratus Plane Block During Pleural Drainage in Intensive Care Unit.
EU CTIS ID: 2024-515722-83-00
What this study is testing
Evaluate the impact of serratus block compared to local anesthesia, on the management of acute pain during the performance of pleural drainage in multipurpose intensive care unit.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patient aged 18 or over, not intubated, spontaneously ventilating.
- Free and informed consent signed.
- Affiliate to a social security scheme.
- Hospitalized in multipurpose intensive care unit including surgical resuscitation, cardiothoracic and respiratory resuscitation or continuing cardiothoracic and respiratory care services.
- Requiring gas or fluid pleural drainage.
You likely can't join if
- Patient didn't agree to participate in the trial.
- Patient under guardianship or curatorship or deprived of liberty.
- Pregnant, parturient or breastfeeding woman.
- Allergy and contraindication to Lidocaine or Ropivacaine.
- Coagulation disorders.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.